Unlocking the full potential of cell therapies for patients around the world

Joined May 2013
261 Photos and videos
23 Mar 2023
SQZ Biotechnologies Announces Confirmed Complete Response in HPV16 Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial investors.sqzbiotech.com/new… $SQZ
1
5
962
14 Nov 2022
In recognition of #WorldDiabetesDay, we’re revisiting this #HowCellsWork episode, which looks at how immune tolerance therapies could change the treatment paradigm for #Type1Diabetes & improve patient quality of life. Cc @JDRF
5
7
10 Nov 2022
At #mRNA2022 today, @ilkeremrahozay presented on how the Cell Squeeze® Technology can be used to generate Enhanced Antigen Presenting Cells (SQZ® eAPCs) that amplify CD8 T cell responses  @mrnaconference
3
5
10 Nov 2022
At #SITC22, we shared preclinical data showing that SQZ® eAPCs with mRNA encoding multiple linked antigens could represent a potential model for a personalized neoantigen medicine for mutations like #KRAS: buff.ly/3WQUNfx $SQZ #CellTherapy
1
1
6
SQZ Biotechnologies ($SQZ) Reports Third Quarter 2022 Financial Results and Recent Portfolio Updates: buff.ly/3UE4w7H
1
2
At #SITC22, we’ll be presenting 3 posters, which highlight: - our Cell Squeeze® platform - linked antigen mRNA preclinical research - our COMMANDER-001 (SQZ® eAPC) Trial in Progress $SQZ
2
4
We are pleased to share the Clinical Trials and Immunotherapy for Head and Neck Cancer webinar. Presented by @SQZBiotech, SPOHNC and @hncalliance. Much thanks and appreciation to our guest speakers. youtu.be/JsEWMM-rh9w

1
1
SQZBiotech retweeted
We are happy to share the recording of the webinar, Clinical Trials and Immunotherapy for Head and Neck Cancer: 3 Different Perspectives (Presented by SQZ Biotechnologies, SPOHNC and Head and Neck Cancer Alliance)youtu.be/OG8P6Zhapjs
1
4
25 Oct 2022
About 70% of oropharyngeal cancers are linked to human papillomavirus (HPV). In this #HowCellsWork episode, we explore how #HPV can cause #headandneckcancer:
1
2
SQZBiotech retweeted
Ragon Seminar Tuesday 10/25 at noon ET: Join us for a presentation by @ArmonSharei, CEO and founder @SQZBiotech. Sign up for our seminar email list: eepurl.com/gY8tUP
1
2
11 Oct 2022
Join us tomorrow 10/12 with @spohnc_1 & @hncalliance for a webinar on clinical trials and #immunotherapy for #headandneckcancers. Learn more and register at: buff.ly/3SO729W
2
3
11 Oct 2022
Stephane Calmat, PhD, SQZ Director of Analytical Development, presents on "Early adoption of RMM technologies to enable novel cell therapies for patient needs" at @PDAonline Microbiology Conference Cc @MilliporeSigma
1
1
3
In his @INVIVOnow article, SQZ CEO @ArmonSharei discusses both the challenges and the promise for patients in advancing #celltherapies in oncology. Read the article: buff.ly/3EqHhsf
2
3
Join us with @spohnc_1 & @hncalliance on 10/12 for a webinar on clinical trials and #immunotherapy for #headandneckcancers. Learn more and register at: buff.ly/3SO729W
1
2
2
Preclinical data published in @FrontImmunol demonstrates that SQZ® Activating Antigen Carriers (AACs) have the potential to be an effective red blood cell-derived cancer #immunotherapy. Learn more: buff.ly/3SP86dM #celltherapy
3
2
28 Sep 2022
We are proud to sponsor @HPVAnalCancer’s Patient Summit, a full day of expert sessions focused on #analcancer treatment, side effects, prevention, and community. Learn more & register at: tinyurl.com/ACFSummit22
4
2
27 Sep 2022
Join SQZ CEO @ArmonSharei at #BiotechWeekBoston on 9/28 for a panel on “Beyond Rare Diseases - Overcoming the Challenges of Expanding to Larger Patient Populations with Cell and Gene Therapies” with @Atarabio & @BioCentriq buff.ly/3Ravq4a
3
5
24 Sep 2022
It’s #WorldCancerResearchDay. Today and every day, we’re working to advance treatments for cancer patients. Learn more about how our clinical trials seek to put patients’ own immune systems to work to fight their cancer: buff.ly/3doHpO5
2
3
22 Sep 2022
Join SQZ CEO & @MIT alum @ArmonSharei as he presents the inaugural Charles L. Cooney Lecture @MITChemE on Friday, 9/23 at 3pm: buff.ly/3qSDewK Cc @MIT_alumni @MITEngineering @MITdeptofBE
1
5
20 Sep 2022
Join SQZ CEO @ArmonSharei on 9/21 for a panel on “The Next Wave of Targeted Therapies” at the #LongwoodHealthcareLeaders Webconference. Learn more: buff.ly/3R3s1nQ Cc @LongwoodLeaders
2
4